Table 2.
Clinical presentation in ILI patients (Group 3)
| Demographic parameter | Total (n = 19) |
ILI patients with COVID-19 (n = 15) |
ILI patients without Covid-19 (n = 4) |
p value |
|---|---|---|---|---|
| Age (years) | ||||
| Median (range) | 32 (0.2–75 years) | 30 (0.5–60 years) | 53 (0.2–75 years) | 0.073 |
| Gender | ||||
| Male | 10 (52.6%) | 8 (53.3%) | 2 (50%) | 0.906 |
| Female | 9 (47.3%) | 7 (46.6%) | 2 (50%) | |
| Symptoms | ||||
| Cough | 17 (89.4%) | 13 (86.6%) | 4 (100%) | 0.44 |
| Fever | 15 (78.9%) | 11 (73.3%) | 4 (100%) | 0.245 |
| Sore throat | 13 (68.4%) | 13 (86.6%) | 0 (0%) | 0.001* |
| Body ache | 2 (10.5%) | 1 (6.6%) | 1 (25%) | 0.288 |
| Sputum | 1 (5.2%) | 1 (6.6%) | 0 (0%) | 0.59 |
| Haemoptysis | 1 (5.2%) | 1 (6.6%) | 0 (0%) | 0.596 |
*p value < 0.05-Significant